Read BioSpace’s recent coverage of LexaGene’s plans to submit for FDA Emergency Use Authorization, and how the MiQLab™ system is ideally suited to test for COVID-19 variants at point-of-care.
![Biospace-image-thumb[1]](https://lexagene.com/wp-content/uploads/2021/11/Biospace-image-thumb1.png)
BioSpace Coverage on LexaGene EUA Studies
LexaGene
LexaGene develops fully automated, rapid molecular testing at the point-of-need for accurate pathogen detection in human clinical diagnostics, veterinary diagnostics, food safety, and other markets.
Upcoming Events
No events in this category to show at this time.
Latest Resources
In this study, slow-growing bacterium and typical contaminant, C. acnes, was challenged for microbial detection utilizing both LexaGene’s MiQLab System and anaerobic culture.